非感染性葡萄膜炎的眼内治疗
Intraocular therapy in noninfectious uveitis.
作者信息
Modugno Rocco Luigi, Testi Ilaria, Pavesio Carlos
机构信息
Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua, Italy.
Moorfields Eye Hospital, National Health Service Foundation Trust, 162 City Rd, Old Street, London, EC1V 2PD, UK.
出版信息
J Ophthalmic Inflamm Infect. 2021 Oct 10;11(1):37. doi: 10.1186/s12348-021-00267-x.
Abstract
Systemic corticosteroids and immunosuppressant agents are the mainstay of therapy for non-infectious uveitis (NIU). However, the risks associated with systemic administration and the need of delivering an effective and safe anti-inflammatory treatment targeted to the site of inflammation have prompt the use of local therapy in the management of NIU. This review will analyse the different local treatment options available, including corticosteroids, anti-vascular endothelial growth factor (VEGF), methotrexate and the recent biologics.
摘要
全身用皮质类固醇和免疫抑制剂是治疗非感染性葡萄膜炎（NIU）的主要手段。然而，全身给药相关的风险以及需要针对炎症部位提供有效且安全的抗炎治疗，促使人们在NIU的治疗中采用局部治疗。本综述将分析现有的不同局部治疗选择，包括皮质类固醇、抗血管内皮生长因子（VEGF）、甲氨蝶呤以及最近的生物制剂。
相似文献
1
Intraocular therapy in noninfectious uveitis.
J Ophthalmic Inflamm Infect. 2021 Oct 10;11(1):37. doi: 10.1186/s12348-021-00267-x.
2
Efficacy and safety of intravitreal anti-tumour necrosis factor drugs in adults with non-infectious uveitis - a systematic review.
Acta Ophthalmol. 2018 Sep;96(6):e665-e675. doi: 10.1111/aos.13699. Epub 2018 Mar 25.
3
New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review.
Semin Arthritis Rheum. 2019 Dec;49(3):438-445. doi: 10.1016/j.semarthrit.2019.06.004. Epub 2019 Jun 10.
4
Local versus Systemic Therapy for Noninfectious Uveitis (NIU).
Semin Ophthalmol. 2023 Jan;38(1):15-23. doi: 10.1080/08820538.2022.2152707. Epub 2022 Dec 5.
5
Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies.
Ophthalmology. 2018 Dec;125(12):1984-1993. doi: 10.1016/j.ophtha.2018.06.015. Epub 2018 Jul 27.
6
Perspectives for immunotherapy in noninfectious immune mediated uveitis.
Expert Rev Clin Immunol. 2021 Sep;17(9):977-989. doi: 10.1080/1744666X.2021.1956313. Epub 2021 Jul 26.
7
Management of noninfectious posterior uveitis with intravitreal drug therapy.
Clin Ophthalmol. 2016 Oct 13;10:1983-2020. doi: 10.2147/OPTH.S89341. eCollection 2016.
8
Current Knowledge of Biologics in Treatment of Noninfectious Uveitis.
J Ocul Pharmacol Ther. 2022 Apr;38(3):203-222. doi: 10.1089/jop.2021.0098. Epub 2022 Feb 8.
9
Local treatment of infectious and noninfectious intermediate, posterior, and panuveitis: current concepts and emerging therapeutics.
Curr Opin Ophthalmol. 2020 May;31(3):174-184. doi: 10.1097/ICU.0000000000000651.
10
New Pharmacological Strategies for the Treatment of Non-Infectious Uveitis. A Minireview.
Front Pharmacol. 2020 May 8;11:655. doi: 10.3389/fphar.2020.00655. eCollection 2020.
引用本文的文献
1
Update on non-infectious uveitis treatment: anti-TNF-alpha and beyond.
Front Ophthalmol (Lausanne). 2024 Aug 2;4:1412930. doi: 10.3389/fopht.2024.1412930. eCollection 2024.
2
Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations.
J Ophthalmic Inflamm Infect. 2024 May 30;14(1):22. doi: 10.1186/s12348-024-00402-4.
3
Corticosteroid implants for chronic non-infectious uveitis.
Cochrane Database Syst Rev. 2023 Aug 29;8(8):CD010469. doi: 10.1002/14651858.CD010469.pub4.
4
Systemic Administration of Acazicolcept, a Dual CD28 and Inducible T cell Costimulator Inhibitor, Ameliorates Experimental Autoimmune Uveitis.
Transl Vis Sci Technol. 2023 Mar 1;12(3):27. doi: 10.1167/tvst.12.3.27.
5
Treatment of Non-Infectious Posterior Uveitis with Dexamethasone Intravitreal Implants in a Real-World Setting.
Clin Ophthalmol. 2023 Feb 16;17:601-611. doi: 10.2147/OPTH.S393662. eCollection 2023.
6
Corticosteroid implants for chronic non-infectious uveitis.
Cochrane Database Syst Rev. 2023 Jan 16;1(1):CD010469. doi: 10.1002/14651858.CD010469.pub3.
7
Efficacy and Safety of Tocilizumab in the Management of Non-Infectious Uveitis Failed with Conventional Immunomodulatory and Anti-TNFα Therapies.
Ocul Immunol Inflamm. 2024 Aug;32(6):891-897. doi: 10.1080/09273948.2022.2126374. Epub 2022 Dec 21.
8
Commentary: Dexamethasone intravitreal implant therapy in Vogt-Koyanagi-Harada disease.
Indian J Ophthalmol. 2022 Jul;70(7):2470-2471. doi: 10.4103/ijo.IJO_1207_22.
本文引用的文献
1
Evaluation of fluocinolone acetonide 0.19 mg intravitreal implant in the management of birdshot retinochoroiditis.
Br J Ophthalmol. 2022 Feb;106(2):234-240. doi: 10.1136/bjophthalmol-2020-317372. Epub 2020 Nov 26.
2
Seven-Year Outcomes of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study Results.
Ophthalmology. 2021 May;128(5):719-728. doi: 10.1016/j.ophtha.2020.08.035. Epub 2020 Sep 10.
3
Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results.
Ophthalmology. 2020 Oct;127(10):1395-1404. doi: 10.1016/j.ophtha.2020.04.001. Epub 2020 Apr 17.
4
Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Program.
Ophthalmology. 2020 Oct;127(10):1405-1415. doi: 10.1016/j.ophtha.2020.03.033. Epub 2020 Apr 3.
5
Uveitis Therapy: The Corticosteroid Options.
Drugs. 2020 Jun;80(8):765-773. doi: 10.1007/s40265-020-01314-y.
6
Preliminary evaluation of YUTIQ™ (fluocinolone acetonide intravitreal implant 0.18 mg) in posterior uveitis.
Ther Deliv. 2019 Oct;10(10):621-625. doi: 10.4155/tde-2019-0051. Epub 2019 Oct 30.
7
Intravitreal Dexamethasone Implant for Treatment of Sarcoidosis-Related Uveitis.
Adv Ther. 2019 Aug;36(8):2137-2146. doi: 10.1007/s12325-019-00989-4. Epub 2019 May 28.
8
Dexamethasone implantation in birdshot chorioretinopathy - long-term outcome.
Int Med Case Rep J. 2018 Nov 30;11:349-358. doi: 10.2147/IMCRJ.S164206. eCollection 2018.
9
Toxicity and in vivo release profile of sirolimus from implants into the vitreous of rabbits' eyes.
Doc Ophthalmol. 2019 Feb;138(1):3-19. doi: 10.1007/s10633-018-9664-8. Epub 2018 Nov 19.
10
Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment: Twelve-Month Results.
Ophthalmology. 2019 Apr;126(4):601-610. doi: 10.1016/j.ophtha.2018.10.033. Epub 2018 Oct 25.
Zotero 插件